Notice ID: bed30be49de944bd967346bba462ec58Sources Sought
Notice of Intent to Sole Source Cerus Drop Shipment of OEM & FDA approved Platelet Sets INT2140B & INT2540B for U.S. Naval Hospital Okinawa - Pacific Command Armed Services Blood Bank Center (USNHO PACOM ASBBC)
Archived on April 26, 2024. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 8:00 AM UTC−07:00
- Posted
- March 27, 2024
- Notice type
- Sources Sought
- NAICS
- 325413: In-Vitro Diagnostic Substance Manufacturing
- Agency
- Department of WarDEFENSE HEALTH AGENCY (DHA)
Notice details
- Office
- DEFENSE HEALTH AGENCY
- Last updated
- Dec 4, 2025
Identifiers
- Solicitation number
- HT941024N0047
- Notice ID
- bed30be49de944bd967346bba462ec58
Description
Notice of Intent to Sole Source HT941024N0047 THIS IS A NOTICE OF INTENT TO AWARD A SOLE SOURCE NON-PERSONAL SERVICES CONTRACT AND IS NOT A REQUEST FOR COMPETITIVE QUOTES. The Defense Health Agency Contracting Activity (DHACA), Western Markets Contracting Division (WMCD), San Diego, intends to negotiate and award a firm fixed price contract for Intercept Platelet Small Volume Set (INT 2140B) and Intercept Dual Storage Processing Set (INT2540B), Outside the Continental of the United States (OCONUS) in support of United States Naval Hospital Okinawa (USNHO), Japan - Pacific Command Armed Services Blood Bank Center (PACOM ASBBC) in accordance with Federal Acquisition Regulation FAR 13.106-1(b)(1)(i), only one source being available to meet the Governments needs, to: CERUS CORPORATION 1220 Concord Ave STE 600 Concord, CA 94520-4906 The North American Industry Classification System (NAICS) code for this requirement is 325413 In-Vitro Diagnostic Substance Manufacturing, the business size standard is 1,250 # of employees. The Product Service Code (PSC) is 6550 In-Vitro Diagnostic Substances, Reagents, Test Kits and Sets. The objective of this sole source award is to procure supplies for U. S. Pacific Command Armed Services Blood Bank Center (USPACOM ASBBC). USPACOM ASBBC requires for regular drop shipment of platelet small volume processing sets and dual storage processing sets used for two (2) Cerus Corporation manufactured Intercept Illuminator Pathogen Reduction equipment. The anticipated period of performance is for a base with four (4) option periods. This notice of intent is not a request for competitive proposals, and no solicitation document exists for this requirement. Sources interested in responding to this notice are required to submit a capability statement that includes management and technical data and cost information, in sufficient detail and with convincing evidence that clearly demonstrates the capability to provide the required services for United States Naval Hospital Okinawa. Capability statements shall not exceed six (8.5 x 11 inch) pages using a font size no smaller than 10-point. All capability statements received by the due date of this notice will be considered by the Government. A request for documentation or additional information or submissions that only ask questions will not be considered as an affirmative response. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement or to proceed with a sole source purchase order. If a vendor challenges the basis of this requirement, please email capability statements as a Microsoft Word or Adobe PDF attachment to Adrian Nerida at adrian.m.nerida.civ@health.mil. The closing date for challenges is no later than 8:00am Pacific Daylight Time, 11 April 2024. NO TELEPHONE REQUESTS/OFFERS WILL BE HONORED.
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Documents
No documents available.
Lifecycle
Solicitation:
HT941024N0047- Market Research
Pre-solicitation or formal solicitation typically follows within 30–180 days. (estimate)
- Market ResearchCurrentMar 27, 2024
Notice of Intent to Sole Source Cerus Drop Shipment of OEM & FDA approved Platelet Sets INT2140B & INT2540B for U.S. Naval Hospital Okinawa - Pacific Command Armed Services Blood Bank Center (USNHO PACOM ASBBC)
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Phadia 250 Reagent and Consumables | - | Awarded | Open |
DLA – TS E&A, in conjunction with the United States Army Medical Materiel Center-Europe (USAMMCE), is conducting market research to support the recompete of its commercial laboratory supplies contract. The resulting contract will provide clinical laboratory reagents, test cartridges, calibrators, controls, and associated consumables that operate in conjunction with specific Government-owned laboratory analyzers and capital equipment (e.g., Abbott i-STAT, Siemens DCA 2000, and other point-of-care or automated platforms). The primary ordering activity and logistics hub is USAMMCE, servicing Department of Defense (DoD) medical treatment facilities and operational forces across the European Command (EUCOM) and possibly Central Command (CENTCOM) theaters. The follow-on ordering period is projected to commence on 15 January 2028. | - | Market Research | 10/30/2026 |
This requirement for reagents, quality control, maintenance, consumables, and two (2) automated urine laboratory analyzers for use at United States Naval Health Clinic Hawaii (NHCH) Makalapa and Branch Health Clinic Kaneohe Bay was awarded as a firm-fixed-price, sole source, supply contract to Beckman Coulter, Inc. pursuant to FAR Subpart 13.5 and in accordance with 41 U.S.C. 1901 Simplified Acquisition Procedures after receiving no additional information from interested parties in response to Notice of Intent to Sole Source HT941023N0020. | - | Awarded | Open |
Attached is the award for Trazodone. | - | Awarded | Open |
Redacted J&A posted in accordance with RFO 6.301 | - | Sole Source / J&A | Open |
Additional Details
Solicitation Number
HT941024N0047
Archive Date
Apr 26, 2024
Place of Performance Country
JPN
Office Address
FALLS CHURCH, VA, 22042